• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Evidence-based Practice
      Center for Medical Technology Assessment
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      Healthcare Improvement Scotland
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute for Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafe BC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osteochondral allograft transplantation for the knee (or other joints)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allograft for anterior and posterior cruciate ligament reconstruction
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Human dermal allograft for massive rotator cuff tears
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for Diabetes mellitus: guideline recommendations
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) FoundationOne®CDx: genetic profiling of solid tumours
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review
2019     Center for Drug Evaluation (CDE) Assessment of the benefits of community day-care facilities for the physically and mentally handicapped
2019     Adelaide Health Technology Assessment (AHTA) Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for myasthenia gravis
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT)
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Adelaide Health Technology Assessment (AHTA) Heritable Mutations associated with Familial Hypercholesterolaemia
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Health Technology Wales (HTW) Continuous glucose monitoring systems for managing diabetes in pregnant women
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Technology Wales (HTW) Pharmacogenetic testing to identify the risk of adverse reactions to anti-epileptic medications
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Health Technology Wales (HTW) Robot-assisted thoracic surgery
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Technology Wales (HTW) Occipital nerve stimulation for medically refractory chronic cluster headache
2019     Health Sciences Institute in Aragon (IACS) Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019     Health Sciences Institute in Aragon (IACS) Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019     Health Technology Wales (HTW) Multi-grip myoelectric upper-limb prosthetics
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     Ontario Health Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients’ Experiences, Preferences, and Values
2019     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 1: A rapid review
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Enzalutamide (prostate cancer) - Addendum to Commission A18-80]
2019     Basque Office for Health Technology Assessment (OSTEBA) Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements
2019     Basque Office for Health Technology Assessment (OSTEBA) Indications, utility and use of ultrasound in primary care
2019     Basque Office for Health Technology Assessment (OSTEBA) Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants
2019     Belgian Health Care Knowledge Centre (KCE) Bariatric surgery : an HTA report on the efficacy, safety and cost-effectiveness
2019     Basque Office for Health Technology Assessment (OSTEBA) Methodological project: Synthesis of information in support of multicriteria decision analysis (MCDA) for decision making
2019     Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness analysis of HPV vaccination of boys in Belgium
2019     Belgian Health Care Knowledge Centre (KCE) The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
2019     Belgian Health Care Knowledge Centre (KCE) Proton beam therapy in adults
2019     Belgian Health Care Knowledge Centre (KCE) Statins for the primary prevention of cardiovascular events
2019     NIHR Health Services and Delivery Research programme Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes and evaluation of tools for measuring outcomes of care: rapid evidence synthesis
2019     NIHR Health Services and Delivery Research programme Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review
2019     NIHR Health Services and Delivery Research programme Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2019     NIHR Health Services and Delivery Research programme Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review
2018     NIHR Health Technology Assessment programme Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018     NIHR Health Technology Assessment programme Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir (hepatitis C in adolescents) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Brain and spinal stimulation therapies for phantom limb pain: a systematic review
2018     NIHR Health Technology Assessment programme Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obinutuzumab (non-pretreated advanced follicular lymphoma) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Midostaurin (acute myeloid leukaemia) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telotristat ethyl (carcinoid syndrome diarrhoea) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Guidelines for Electrocardiography on Arrival to the Emergency Department
2018     Center for Evidence-based Practice (CEP) Guidelines for Management of Acute Hydronephrosis
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dropouts in Psychotherapy. Part I: Predictors, theories and models to explain and recommend courses of action to avoid discontinuation of therapy. Part II: "Overview of Reviews" on dropouts in psychotherapy
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2018     NIHR Public Health Research (PHR) programme Child food insecurity in the UK: a rapid review
2018     Adelaide Health Technology Assessment (AHTA) Extended half-life clotting factor concentrates for the treatment of haemophilia A and B
2018     Adelaide Health Technology Assessment (AHTA) Anti-Mullerian Hormone (AMH) testing for female patients who will or have received gonadotoxic treatment
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osimertinib (Tagrisso®) for the initial treatment of EGFR-mutated advanced non–small-cell lung cancer (NSCLC)
2018     Norwegian Institute for Public Health EXOGEN™ in the treatment of non-union fractures. A single technology assessment
2018     Norwegian Institute for Public Health Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA
2018     Norwegian Institute for Public Health Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment
2018     Norwegian Institute for Public Health The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment
2018     Norwegian Institute for Public Health 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment
2018     Norwegian Institute for Public Health Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018     Norwegian Institute for Public Health Bariatric surgery for Type 2 Diabetes and a body mass index below 35
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Daratumumab (Darzalex®) in combination with bortezomib, melphalan and prednisone for untreated myeloma
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Endobronchial valve implantation for emphysema. Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) High-intensity focused ultrasound for the treatment of prostate cancer. 1st Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Subcutaneous implantable cardioverter defibrillator (ICD)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lymphovenous anastomoses in patients with primary and secondary lymphoedema
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas